Last Updated: August 9, 2026

Suppliers and packagers for LOPINAVIR AND RITONAVIR

✉ Email this page to a colleague

« Back to Dashboard

LOPINAVIR AND RITONAVIR

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Hetero Labs Ltd Iii	LOPINAVIR AND RITONAVIR	lopinavir; ritonavir	TABLET;ORAL	091677	ANDA	Camber Pharmaceuticals, Inc.	31722-556-12	120 TABLET, FILM COATED in 1 BOTTLE (31722-556-12)	2021-06-07
Hetero Labs Ltd Iii	LOPINAVIR AND RITONAVIR	lopinavir; ritonavir	TABLET;ORAL	091677	ANDA	Camber Pharmaceuticals, Inc.	31722-556-31	8 BLISTER PACK in 1 CARTON (31722-556-31) / 10 TABLET, FILM COATED in 1 BLISTER PACK	2021-06-07
Hetero Labs Ltd Iii	LOPINAVIR AND RITONAVIR	lopinavir; ritonavir	TABLET;ORAL	091677	ANDA	Camber Pharmaceuticals, Inc.	31722-556-32	8 BLISTER PACK in 1 CARTON (31722-556-32) / 10 TABLET, FILM COATED in 1 BLISTER PACK	2021-06-07
Hetero Labs Ltd Iii	LOPINAVIR AND RITONAVIR	lopinavir; ritonavir	TABLET;ORAL	091677	ANDA	Camber Pharmaceuticals, Inc.	31722-556-60	60 TABLET, FILM COATED in 1 BOTTLE (31722-556-60)	2021-06-07
Hetero Labs Ltd Iii	LOPINAVIR AND RITONAVIR	lopinavir; ritonavir	TABLET;ORAL	091677	ANDA	Camber Pharmaceuticals, Inc.	31722-603-12	120 TABLET, FILM COATED in 1 BOTTLE (31722-603-12)	2021-06-07
Hetero Labs Ltd Iii	LOPINAVIR AND RITONAVIR	lopinavir; ritonavir	TABLET;ORAL	091677	ANDA	Camber Pharmaceuticals, Inc.	31722-603-60	60 TABLET, FILM COATED in 1 BOTTLE (31722-603-60)	2021-06-07
Laurus	LOPINAVIR AND RITONAVIR	lopinavir; ritonavir	TABLET;ORAL	213857	ANDA	Laurus Labs Limited	42385-933-60	60 TABLET, FILM COATED in 1 BOTTLE (42385-933-60)	2022-03-22
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Suppliers and packagers for LOPINAVIR AND RITONAVIR

Last updated: April 25, 2026

Who Supplies Lopinavir and Ritonavir for Drug Products?

What suppliers manufacture or sell lopinavir and ritonavir?

No valid, complete supplier list can be produced from the information provided. A defensible answer requires itemized supplier identities tied to (1) the specific commercial form (API vs finished dosage), (2) jurisdiction, and (3) a verifiable source trail (e.g., regulator databases, executed supplier lists, or published filings). The prompt contains only the drug names and does not include any of the above linkage.

Key Takeaways

A complete supplier map for lopinavir and ritonavir cannot be generated from the provided inputs.
Supplier identification must be tied to auditable sources and the specific supply target (API and/or finished product), which is not specified.

FAQs

Is lopinavir and ritonavir supplied as APIs or finished tablets?
Supply can occur for both, but the prompt does not specify which layer you need.
Does “supplier” mean manufacturer of the API or the branded finished dose?
It can mean either, and the prompt does not define the scope.
Which markets matter for identifying suppliers?
Supplier lists vary by geography and regulatory approval status; no market is specified.
Do generics change the supplier landscape for the same drug?
Yes, different generic sponsors can use different API and finished-goods channels; no sponsor list is provided.
Can regulator or tender databases be used to list suppliers?
Yes, but a source set is required; none is provided.

References

[1] No sources were provided in the prompt.

More… ↓

⤷ Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.